ADMA Biologics, Inc. (NASDAQ:ADMA) Q1 2023 Earnings Call Transcript May 10, 2023
ADMA Biologics, Inc. beats earnings expectations. Reported EPS is $-0.03, expectations were $-0.04.
Operator: Good afternoon. And welcome to the ADMA Biologics First Quarter 2023 Financial Results and Corporate Update Conference Call on Wednesday, May 10, 2023. At this time, all participants are in a listen only mode. There will be a question-and-answer session to follow. Please be advised that this call is...
